Persistent Müllerian Duct Syndrome - A Rare but Important Cause of Male Factor Infertility

Only 1 in 5 men with PMDS have conceived naturally at time of diagnosis; most present with cryptorchidism or hernias

Journal: Nature Reviews Urology | Published: 2025-11-07 | Type: Review | PMID: 41203848 Authors: George Michael et al. (Manchester Royal Infirmary / Manchester University NHS Foundation Trust, Manchester Andrology Research Collaborative, University of Manchester) Funding/COI: Funding not listed; no competing interests declared

Summary

Persistent Müllerian duct syndrome (PMDS) is a disorder of sex development in 46,XY males where Müllerian duct structures — fallopian tubes, uterus, upper vagina — fail to regress due to deficiency of Müllerian Inhibiting Factor (MIF) secreted by Sertoli cells. Externally, these men look typically male. Internally, they carry female reproductive anatomy that can obstruct fertility or undergo malignant transformation. The condition is underdiagnosed because it usually surfaces incidentally during surgery for cryptorchidism or hernia.

Claims

• At diagnosis, only 1 in 5 men with PMDS have conceived naturally
• Infertility arises from three distinct mechanisms: cryptorchidism (impaired spermatogenesis from malpositioning), anatomical malformations such as epididymal aplasia, or extrinsic compression of the ejaculatory duct by Müllerian structures
• Two anatomical variants exist: the male type (80–90% of cases), presenting with unilateral cryptorchidism and contralateral inguinal hernia; and the female type (10–20%), with bilateral cryptorchidism and testes fixed in an "ovarian position" within the pelvis
• Malignant transformation risk applies to both ectopic testes and Müllerian remnants, similar in magnitude to cryptorchidism generally
• Early orchidopexy is identified as the key initial intervention to preserve spermatogenesis
• Assisted reproductive techniques can support conception after anatomical management

Study Quality

This is a narrative review, not a systematic review or meta-analysis, so it does not pool effect sizes or systematically evaluate evidence quality. The authors provide a clinically useful framework — embryology, classification, surgical options, malignancy surveillance — but the evidence base for PMDS management is inherently thin because the condition is rare. No randomized data exist and likely never will given case rarity; management recommendations derive from case series, case reports, and extrapolation from broader cryptorchidism literature.

The paper's core statistic — 1 in 5 men with PMDS having conceived naturally — is stated without a citation to a primary source in the abstract, which is a notable gap for what is the headline finding.

Red Flags

• Narrative review design: author-selected literature, no systematic search criteria reported, no PRISMA flow diagram
• The "1 in 5 natural conception" figure lacks an explicit primary citation in the abstract text
• Sample sizes across the referenced literature are not aggregated; PMDS series are typically single-digit or low double-digit case counts
• Funding not disclosed — unusual for a Nature Reviews journal article, though COI declaration is clean
• Manchester-heavy author list; no external independent commentary on management recommendations
• No quantification of malignancy risk with confidence intervals or comparison to general cryptorchidism rates

Strengths

• Published in Nature Reviews Urology, a high-impact specialty journal with structured peer review
• Covers the full clinical arc: embryology, anatomical classification, fertility impact, malignancy surveillance, multidisciplinary management
• No industry funding declared; authors declare no competing interests
• Directly addresses a diagnostic blind spot — PMDS is frequently found incidentally during surgery, meaning clinicians may encounter it without awareness
• Practical guidance for a condition where clinical decision-making guidance is sparse

Verdict

This review will not change clinical practice because it cannot — the condition is too rare for controlled trials and the existing evidence too thin for strong recommendations. What it does do is consolidate scattered case literature into a single accessible reference for urologists who encounter PMDS unexpectedly during hernia repair or cryptorchidism surgery. The 1-in-5 natural conception figure, if its sourcing is robust, is the number worth filing. Clinicians in pediatric urology or andrology should read it; general urologists should know it exists.